Winton Group’s CareDx CDNA Stock Holding History
Bought
Maintained
Sold
Other funds holding CDNA
AIM
DM
B
GS
Winton Group's CDNA Position: Q1 2026 in Review
Winton Group sold out of CareDx (CDNA) in Q1 2026, closing a stake of 12,177 shares — an estimated $229K sold.
Winton Group first reported a position in CDNA in Q1 2019 and held it in 6 quarters. The position peaked at $471K in Q4 2019. 191 funds tracked by Wall St. Rank hold CDNA as of Q1 2026.
- Winton Group reported no remaining CareDx position as of Q1 2026 after selling out during the quarter.
- Winton Group sold 12,177 CareDx shares in Q1 2026, an estimated $229K.
- Winton Group first reported a position in CareDx in Q1 2019 and held it in 6 quarters.
- Winton Group's CareDx position peaked at $471K in Q4 2019.
- 191 funds tracked by Wall St. Rank held CareDx as of Q1 2026.
Based on Winton Group's 13F filing for Q1 2026, filed 12 May 2026.